A Phase 1 Open-label, Radiolabeled, Single-Dose Study To Investigate The Absorption, Distribution, Metabolism, And Excretion Of [14c]PF-06463922 In Healthy Male Volunteers
Phase of Trial: Phase I
Latest Information Update: 09 Dec 2015
At a glance
- Drugs Lorlatinib (Primary)
- Indications Non-small cell lung cancer
- Focus Pharmacokinetics
- Sponsors Pfizer
- 03 Dec 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 23 Oct 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 05 Oct 2015 New trial record